Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q1 EPS of ($0.36), $0.03 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $1.17 million.

For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.